Time to reconsider the role of sentinel lymph node biopsy in melanoma

被引：23
|
作者：
Bigby, Michael [1 ,2 ]
Zagarella, Samuel [3 ]
Sladden, Michael [4 ]
Popescu, Catalin M. [5 ]
机构：
[1] Harvard Med Sch, Dept Dermatol, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[3] Univ Sydney, Dept Dermatol, Sch Med, Sydney, NSW, Australia
[4] Univ Tasmania, Dept Med, Sch Med, Launceston, Tas, Australia
[5] Carol Davila Univ Med & Pharm, Bucharest, Romania
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 80卷 / 04期
关键词：
Breslow thickness; hazard ration; immediate completion lymph node dissection; melanoma; multicenter selective lymphadenectomy trial; prognosis; sentinel lymph node biopsy; survival; PROGNOSTIC VALUE; SURVIVAL;
D O I：
10.1016/j.jaad.2018.11.026
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
The Multicenter Selective Lymphadenectomy Trials indicate that there are no overall or melanoma-specific survival advantages to performing sentinel lymph node biopsy (SLNB) followed by immediate completion lymph node dissection compared with wide excision and observation for patients with positive sentinel nodes. These results make SLNB solely a staging procedure. The role of SLNB in the management of patients with melanoma deserves reappraisal. The potential marginal benefit of SLNB beyond the clinical and pathologic features of the melanoma has not been well studied. The use of sentinel lymph node status alone to accept and stratify patients into trials or to receive adjuvant treatment is not rational.
引用
收藏
页码：1168 / 1171
页数：4
相关论文
共 50 条
  • [1] The role of sentinel lymph-node biopsy in the management of cutaneous melanoma
    Crowson, A. N.
    Haskell, H.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2013, 148 (05): : 493 - 499
  • [2] Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma
    Sabran J. Masoud
    Jennifer A. Perone
    Norma E. Farrow
    Paul J. Mosca
    Douglas S. Tyler
    Georgia M. Beasley
    Current Treatment Options in Oncology, 2018, 19
  • [3] Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma
    Masoud, Sabran J.
    Perone, Jennifer A.
    Farrow, Norma E.
    Mosca, Paul J.
    Tyler, Douglas S.
    Beasley, Georgia M.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (11)
  • [4] Role of sentinel lymph node biopsy as a staging procedure in patients with melanoma: A critical appraisal
    Nieweg, Omgo E.
    Cooper, Alan
    Thompson, John F.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2017, 58 (04) : 268 - 273
  • [5] A review of sentinel lymph node biopsy for thin melanoma
    Joyce, K. M.
    McInerney, N. M.
    Joyce, C. W.
    Jones, D. M.
    Hussey, A. J.
    Donnellan, P.
    Kerin, M. J.
    Kelly, J. L.
    Regan, P. J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 (01) : 119 - 123
  • [6] Is sentinel lymph node biopsy of therapeutic relevance for melanoma?
    Möhrle, M
    Schippert, W
    Rassner, G
    Garbe, C
    Breuninger, H
    DERMATOLOGY, 2004, 209 (01) : 5 - 13
  • [7] Desmoplastic Melanoma: Is There a Role for Sentinel Lymph Node Biopsy?
    Dale Han
    Jonathan S. Zager
    Daohai Yu
    Xiuhua Zhao
    Brooke Walls
    Suroosh S. Marzban
    Nikhil G. Rao
    Vernon K. Sondak
    Jane L. Messina
    Annals of Surgical Oncology, 2013, 20 : 2345 - 2351
  • [8] Sentinel Lymph Node Biopsy and Complete Lymph Node Dissection for Melanoma
    Alberto Falk Delgado
    Sayid Zommorodi
    Anna Falk Delgado
    Current Oncology Reports, 2019, 21
  • [9] Sentinel Lymph Node Biopsy and Complete Lymph Node Dissection for Melanoma
    Delgado, Alberto Falk
    Zommorodi, Sayid
    Delgado, Anna Falk
    CURRENT ONCOLOGY REPORTS, 2019, 21 (06)
  • [10] Sentinel Lymph Node Biopsy in Melanoma
    Matthew T. Hueman
    Julie R. Lange
    Current Treatment Options in Oncology, 2008, 9 : 243 - 250
12345